Skip to content

Maravai LifeSciences Holdings, Inc. MRVI Amortization of capitalized software and acquired intangible assets

Amortization of capitalized software and acquired intangible assets at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Danaher logo
DanaherDHR
Illumina logo
IlluminaILMN
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL

Other financials

Income statement

See full
Revenue$65.8M+40.5%
Gross profit$33.7M+336%
Operating income-$2.2M+95.6%
Net income-$3.7M+87.5%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$165.9M-41.8%
Total debt$270.9M-17.1%
Total equity$211.6M-29.6%
Total assets$713.2M-25.7%

Cash flow

See full
Operating cash flow$8.7M+192%
CapEx$4.4M-1.4%
Free cash flow$4.2M+130%

Valuation

See full
Market cap$902.74M+204%
Enterprise value$1.01B+198%
P/S4.4×+3.2×

Profitability

See full
Gross margin29.3%-8.0pp
Operating margin-82.2%-16.6pp
Net margin-51.1%-9.9pp
FCF margin-25.7%

Returns & leverage

See full
Return on equity-40.8%-4.0pp
Debt / equity1.3×+0.2×
Current ratio5.9×-0.1×

Where this comes from

Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Maravai LifeSciences Holdings, Inc.'s amortization of capitalized software and acquired intangible assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Maravai LifeSciences Holdings, Inc.'s amortization of capitalized software and acquired intangible assets?
Maravai LifeSciences Holdings, Inc. (MRVI) reported amortization of capitalized software and acquired intangible assets of $6.47M in Q1 2026.
How has Maravai LifeSciences Holdings, Inc.'s amortization of capitalized software and acquired intangible assets changed year-over-year?
Maravai LifeSciences Holdings, Inc.'s amortization of capitalized software and acquired intangible assets decreased by 7.9% year-over-year, from $7.03M to $6.47M.
What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s amortization of capitalized software and acquired intangible assets?
Over 4 years (2021 to 2025), Maravai LifeSciences Holdings, Inc.'s amortization of capitalized software and acquired intangible assets has grown at a 11.1% compound annual growth rate (CAGR), from $18.34M to $27.95M.